{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:25:44Z","timestamp":1787027144326,"version":"build-2736575974"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver disorder characterized by intrahepatic lipid accumulation, oxidative stress, and inflammatory responses, underscoring the urgent need for effective therapeutic strategies. D-limonene, a cyclic monoterpenoid primarily derived from citrus fruits, possesses well-documented antioxidant, anti-fibrotic, and wound-healing properties. However, its therapeutic potential in MASLD remains largely unexplored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To evaluate the therapeutic efficacy of D-limonene, a rat model of MASLD was established using a high-fat diet (HFD). An integrated approach combining metabolomics, transcriptomics, and network analysis was employed to identify key signaling pathways and molecular targets. The expression levels of candidate targets were validated by RT-qPCR and Western blotting. Molecular docking simulations were performed to predict the binding affinity between D-limonene and the target proteins. Furthermore, a cellular thermal shift assay (CETSA) was conducted to confirm direct binding and protein stabilization. In parallel, cellular experiments using BRL-3A and HepG2 cells were carried out to assess the effect of D-limonene on lipid accumulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>D-limonene treatment significantly ameliorated liver injury, reduced excessive lipid deposition, attenuated inflammation, and suppressed oxidative stress in HFD-induced rats. Integrated multi-omics and network analyses identified the PPAR signaling pathway as the core pathway mediating the regulatory effects of D-limonene on lipid metabolism, with PPAR\u03b3 and SCD-1 pinpointed as key downstream targets. RT-qPCR and Western blot analyses confirmed that D-limonene significantly downregulated the expression of both PPAR\u03b3 and SCD-1. Molecular docking simulations revealed stable binding of D-limonene to PPAR\u03b3 and SCD-1. Importantly, CETSA further demonstrated that D-limonene directly binds to and stabilizes these two proteins. Consistently, cellular assays showed that D-limonene significantly reduced lipid accumulation in BRL-3A and HepG2 cells by inhibiting the PPAR\u03b3\/SCD-1 axis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Collectively, these findings suggest that D-limonene alleviates HFD-induced MASLD, and its protective effects may be mediated, at least in part, through inhibition of the PPAR\u03b3\/SCD-1 axis. This study provides preliminary evidence supporting the potential development of D-limonene as a targeted therapeutic agent for MASLD. Further studies are warranted to validate these findings and elucidate additional underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1843336","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:34:34Z","timestamp":1782970474000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["D-limonene ameliorates metabolic dysfunction-associated steatotic liver disease by inhibiting the PPAR\u03b3\/SCD-1 pathway and improving lipid metabolism disorders"],"prefix":"10.3389","volume":"17","author":[{"given":"Fang","family":"Wang","sequence":"first","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Qing","family":"Liu","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun Nan","family":"Wei","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Fen","family":"Wang","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng Qin","family":"Li","sequence":"additional","affiliation":[{"name":"Teaching and Research Office of Chinese Medicine Resources, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiu Jia","family":"Tian","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Xuan","family":"Gao","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin Zhi","family":"Guo","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue Yan","family":"Li","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Luo","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment, and Rehabilitation of Cancer in Chinese Medicine, Mass Spectrometry Diagnosis and Treatment and Chronic Disease Rehabilitation Research Center, Jiangxi Engineering Research Center for Translational Cancer Technology, Jiangxi University of Chinese Medicine","place":["Nanchang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/tox.22523","article-title":"Antifibrotic effects of D-limonene (5(1-methyl-4-[1-methylethenyl]) cyclohexane) in CCl(4) induced liver toxicity in wistar rats","volume":"33","author":"Ahmad","year":"2018","journal-title":"Environ. Toxicol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ceb.2017.01.005","article-title":"AMPK signalling in health and disease","volume":"45","author":"Carling","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/s1875-5364(24)60690-4","article-title":"Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies","volume":"22","author":"Chen","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s11658-025-00856-x","article-title":"Targeting the sirtuin 6-NF-\u03baB p65 axis by 6-hydroxyhyoscyamine hydrobromide: a deacetylation-driven new therapy for diabetic wounds","volume":"31","author":"Chen","year":"2026","journal-title":"Cell Mol. Biol. Lett."},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.aca.2008.05.012","article-title":"Development of a novel LC\/MS method to quantitate cellular stearoyl-CoA desaturase activity","volume":"627","author":"Dillon","year":"2008","journal-title":"Anal. Chim. Acta"},{"key":"B6","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/s41419-023-05741-z","article-title":"GPAT3 regulates the synthesis of lipid intermediate LPA and exacerbates kupffer cell inflammation mediated by the ERK signaling pathway","volume":"14","author":"Fan","year":"2023","journal-title":"Cell Death Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"156016","DOI":"10.1016\/j.phymed.2024.156016","article-title":"Multi-omics analysis provides new insights into mechanism of didymin on non-alcoholic fatty liver disease in rats","volume":"135","author":"Fang","year":"2024","journal-title":"Phytomedicine"},{"key":"B8","doi-asserted-by":"publisher","first-page":"6418","DOI":"10.1021\/acs.jafc.2c00852","article-title":"Upregulation of 4-hydroxynonenal contributes to the negative effect of n-6 polyunsaturated fatty acid on alcohol-Induced liver injury and hepatic steatosis","volume":"70","author":"Fu","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.bbalip.2012.12.014","article-title":"The human liver fatty acid binding protein (FABP1) gene is activated by FOXA1 and PPAR\u03b1; and repressed by C\/EBP\u03b1: implications in FABP1 down-regulation in nonalcoholic fatty liver disease","volume":"1831","author":"Guzm\u00e1n","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"B10","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jep.2017.08.015","article-title":"Best practice in research: consensus statement on ethnopharmacological field studies - ConSEFS","volume":"211","author":"Heinrich","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab."},{"key":"B13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2013.06.022","article-title":"Preventive and ameliorating effects of citrus D-limonene on dyslipidemia and hyperglycemia in mice with high-fat diet-induced obesity","volume":"715","author":"Jing","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.phymed.2018.07.008","article-title":"Lycopus lucidus turcz. ex benth. Attenuates free fatty acid-induced steatosis in HepG2 cells and non-alcoholic fatty liver disease in high-fat diet-induced obese mice","volume":"55","author":"Lee","year":"2019","journal-title":"Phytomedicine"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1021\/acs.jafc.0c07751","article-title":"Antioxidant activity of docosahexaenoic acid (DHA) and its regulatory roles in mitochondria","volume":"69","author":"Li","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2409126","DOI":"10.1002\/advs.202409126","article-title":"Slow metabolism-driven amplification of hepatic PPAR\u03b3 agonism mediates benzbromarone-induced obesity-specific liver injury","volume":"12","author":"Li","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"156458","DOI":"10.1016\/j.metabol.2025.156458","article-title":"Imeglimin ameliorates MASLD by targeting PEN2 to activate AMPK pathway","volume":"175","author":"Li","year":"2026","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3390\/nu15020267","article-title":"D-Limonene promotes anti-obesity in 3T3-L1 adipocytes and high-calorie diet-induced obese rats by activating the AMPK signaling pathway","volume":"15","author":"Liao","year":"2023","journal-title":"Nutrients"},{"key":"B19","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.3390\/molecules171214765","article-title":"Anti-obesity effect of HT048, a herbal combination, in high fat diet-induced obese rats","volume":"17","author":"Lim","year":"2012","journal-title":"Molecules"},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.seppur.2014.09.015","article-title":"A non-conventional method to extract D-limonene from waste lemon peels and comparison with traditional soxhlet extraction","volume":"137","author":"Lopresto","year":"2014","journal-title":"Sep. Purif. Technol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"117464","DOI":"10.1016\/j.lfs.2020.117464","article-title":"Selenium\/zinc-enriched probiotics improve serum enzyme activity, antioxidant ability, inflammatory factors and related gene expression of wistar rats inflated under heat stress","volume":"248","author":"Malyar","year":"2020","journal-title":"Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3390\/ijms27021066","article-title":"The interplay between cellular senescence and lipid metabolism in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"27","author":"Mastoridou","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1124\/pr.58.4.5","article-title":"International union of pharmacology. LXI. Peroxisome proliferator-activated receptors","volume":"58","author":"Michalik","year":"2006","journal-title":"Pharmacol. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.cmet.2007.10.014","article-title":"Hepatic stearoyl-CoA desaturase-1 deficiency protects mice from carbohydrate-induced adiposity and hepatic steatosis","volume":"6","author":"Miyazaki","year":"2007","journal-title":"Cell Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"101916","DOI":"10.1016\/j.molmet.2024.101916","article-title":"Scd1 and monounsaturated lipids are required for autophagy and survival of adipocytes","volume":"83","author":"Mori","year":"2024","journal-title":"Mol. Metab."},{"key":"B26","first-page":"1","article-title":"NTP toxicology and carcinogenesis studies of d-Limonene (CAS No. 5989-27-5) in F344\/N rats and B6C3F1 mice (gavage studies)","volume":"347","year":"1990","journal-title":"Natl. Toxicol. Program Tech. Rep. Ser."},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fphar.2026.1735481","article-title":"Acetylshikonin mitigates diet-induced MASLD by targeting PPAR\u03b3-mediated metabolic dysfunction","volume":"17","author":"Ou","year":"2026","journal-title":"Front. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3390\/ph18040538","article-title":"Trends and pitfalls in the progress of network pharmacology pesearch on natural products","volume":"18","author":"Panossian","year":"2025","journal-title":"Pharm. (Basel)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"157612","DOI":"10.1016\/j.phymed.2025.157612","article-title":"Single-cell analysis integrated with RNA-sequencing uncovers new action of patchoulol on adipose tissue remodeling in obesity","volume":"150","author":"Qin","year":"2026","journal-title":"Phytomedicine"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1563561","DOI":"10.3389\/fphar.2025.1563561","article-title":"Gallic acid mitigates high-fat and high-carbohydrate diet-induced steatohepatitis by modulating the IRF6\/PPAR\u03b3 signaling pathway","volume":"16","author":"Qiu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.toxrep.2015.01.001","article-title":"Histopathological and biochemical assessment of d-limonene-induced liver injury in rats","volume":"2","author":"Ramos","year":"2015","journal-title":"Toxicol. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J. Hepatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3389\/fphar.2017.00772","article-title":"High concentrations of rosiglitazone reduce mRNA and protein levels of LRP1 in HepG2 cells","volume":"8","author":"Rond\u00f3n-Ortiz","year":"2017","journal-title":"Front. Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40360-025-01054-3","article-title":"Anti-fibrotic and anti-inflammatory effects of D-limonene in improving liver cirrhosis induced by bile duct ligation in male rat","volume":"27","author":"Sabbagh","year":"2025","journal-title":"BMC Pharmacol. Toxicol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","article-title":"Mechanisms for insulin resistance: common threads and missing links","volume":"148","author":"Samuel","year":"2012","journal-title":"Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J. Hepatol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"12892","DOI":"10.1021\/acs.jafc.5c17222","article-title":"Galangin overcomes gefitinib and sotorasib resistance in non-small cell lung cancer by inhibiting efferocytosis","volume":"74","author":"Su","year":"2026","journal-title":"J. Agric. Food Chem."},{"key":"B38","volume-title":"D-Limonene Reduces Body Mass Index in metabolism-associated Fatty Liver Disease: A Randomized, double-blind placebo-controlled Trial","author":"Tan","year":"2025"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1194\/jlr.M050062","article-title":"Fatty acid elongase-5 (Elovl5) regulates hepatic triglyceride catabolism in obese C57BL\/6J mice","volume":"55","author":"Tripathy","year":"2014","journal-title":"J. Lipid Res."},{"key":"B40","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00394-011-0182-7","article-title":"Dietary d-limonene alleviates insulin resistance and oxidative stress-induced liver injury in high-fat diet and L-NAME-treated rats","volume":"51","author":"Victor Antony Santiago","year":"2012","journal-title":"Eur. J. Nutr."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5398","DOI":"10.13040\/ijpsr.0975-8232.5(12).5398-04","article-title":"The effect of cinnamaldehyde on high fat diet induced wistar rats \u2013a preliminary study","volume":"5","author":"Vijayalakshmi","year":"2014","journal-title":"Int. J. Pharm. Sci. Res."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1007\/s11696-025-04469-8","article-title":"Optimization of rapid microwave-assisted extraction and epoxidation of D-limonene from waste orange peels","volume":"80","author":"Visvalingam","year":"2026","journal-title":"Chem. Pap."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1210\/clinem\/dgaf336","article-title":"Efficacy of GLP-1-based therapies on metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a systematic review and meta-analysis","volume":"110","author":"Wang","year":"2025","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B44","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12951-025-03966-y","article-title":"Dual-site spatiotemporal and simultaneous inhibition on PIN1 via arsenic-retinoic albumin nanoparticles enables synergistic oncotherapy","volume":"24","author":"Yang","year":"2025","journal-title":"J. Nanobiotechnology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"115892","DOI":"10.1016\/j.foodres.2025.115892","article-title":"Anti-obesity effects of luteoloside on high fat diet induced obese mice: modulation of white adipose tissue, gut microbiota, and PPAR signaling pathways","volume":"203","author":"Yang","year":"2025","journal-title":"Food Res. Int."},{"key":"B46","doi-asserted-by":"publisher","first-page":"4431","DOI":"10.1210\/jc.2008-0782","article-title":"Stearoyl-coenzyme A desaturase 1 gene expression increases after pioglitazone treatment and is associated with peroxisomal proliferator-activated receptor-gamma responsiveness","volume":"93","author":"Yao-Borengasser","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1565030","DOI":"10.3389\/fphar.2025.1565030","article-title":"Transdermal administration of herbal essential oil alleviates high-fat diet-induced obesity by regulating metabolism and gut microbiota","volume":"16","author":"Ye","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B50","doi-asserted-by":"publisher","first-page":"8536","DOI":"10.1021\/acs.jafc.3c08910","article-title":"Probiotic mixture ameliorates a diet-induced MASLD\/MASH murine model through the regulation of hepatic lipid metabolism and the gut microbiome","volume":"72","author":"Zhang","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"B51","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12935-024-03306-4","article-title":"Identification of fatty acids synthesis and metabolism-related gene signature and prediction of prognostic model in hepatocellular carcinoma","volume":"24","author":"Zhengdong","year":"2024","journal-title":"Cancer Cell Int."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1843336\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:34:36Z","timestamp":1782970476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1843336\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":51,"alternative-id":["10.3389\/fphar.2026.1843336"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1843336","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"article-number":"1843336"}}